Drug Database
L04AC18 risankizumab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Skyrizi 150 mg solution for injection in pre-filled pen (Great Britain) ▼
- POM Skyrizi 150 mg solution for injection in pre-filled syringe (Great Britain) ▼
- POM Skyrizi 360 mg solution for injection in cartridge ▼
- POM Skyrizi 600 mg concentrate for solution for infusion ▼
- POM Skyrizi 75 mg solution for injection in pre-filled syringe
- POM Skyrizi solution for injection in pre-filled syringe and pen (Northern Ireland) ▼
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).